Lord Abbett Health Care R5 (LHCTX)

Fund Assets	8.56M
Expense Ratio	0.78%
Min. Investment	$0.00
Turnover	91.00%
Dividend (ttm)	0.08
Dividend Yield	0.34%
Dividend Growth	-23.07%
Payout Frequency	n/a
Ex-Dividend Date	Dec 2, 2025

Previous Close	25.18
YTD Return	10.33%
1-Year Return	30.14%
5-Year Return	24.38%
52-Week Low	19.44
52-Week High	25.30
Beta (5Y)	n/a
Holdings	57
Inception Date	Jul 31, 2019

About LHCTX

Lord Abbett Health Care Fund Class R5 is an actively managed mutual fund that focuses on delivering long-term capital growth by investing primarily in equity securities of companies within the health care sector. The fund’s portfolio is diversified across areas such as pharmaceuticals, biotechnology, medical devices, and health care services. Managed by Lord Abbett’s experienced investment team, the fund seeks to capitalize on innovation, demographic changes, and advancements within global health care industries. A distinguishing feature of this fund is its commitment to specialization: approximately 96% of its assets are allocated to health care holdings, with a small balance in repurchase agreements. The fund typically holds around 61 securities, providing both sector concentration and diversified exposure within health care. Designed for institutional investors, the Class R5 share class is structured with a lower net expense ratio relative to other share classes, potentially enhancing cost efficiency for larger organizations. With significant assets under management and a portfolio turnover rate that reflects an active approach, the Lord Abbett Health Care Fund Class R5 plays a critical role for investors seeking targeted participation in health care industry growth, making it a relevant vehicle in sector-based investment strategies.

• Fund Family: Lord Abbett
• Category: Health
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: NASDAQ
• Ticker Symbol: LHCTX
• Share Class: Class R5
• Index: MSCI ACWI/Health Care NR Index

Performance

LHCTX had a total return of 30.14% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.71%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
LHCOX	Class F3	0.68%
LHCVX	Class R6	0.68%
LHCIX	Class I	0.78%
LHCFX	Class F	0.78%

Top 10 Holdings

43.78% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	10.93%
UnitedHealth Group Incorporated	UNH	4.48%
AstraZeneca PLC	AZN	4.46%
Guardant Health, Inc.	GH	4.34%
Natera, Inc.	NTRA	3.67%
Gilead Sciences, Inc.	GILD	3.45%
Johnson & Johnson	JNJ	3.37%
CVS Health Corporation	CVS	3.33%
Novartis AG	NOVN	3.01%
Galderma Group AG	GALD	2.74%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 2, 2025	$0.0847	Dec 2, 2025
Nov 26, 2024	$0.1101	Nov 26, 2024
Nov 22, 2022	$0.0233	Nov 22, 2022
Nov 23, 2021	$1.4724	Nov 23, 2021
Nov 24, 2020	$2.3182	Nov 24, 2020
Nov 21, 2019	$0.0069	Nov 21, 2019

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Aug 27, 2026

Data Sources Report a data error